Home Contact

Price: 9.92

Change: - 0.49

Day High: 10.35
Day Low: 9.86
Volume: 150,400

4:00 PM ET | Apr 23, 2014
Delayed 20 min., by eSignal.



Shareholder Tools

Investor Relations

Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.

View all »Events & Presentations

Apr 29, 2014 at 4:30 PM ET
Cempra Inc. First Quarter 2014 Financial and Operating Results